RAC 5.59% $1.70 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-14

  1. 441 Posts.
    lightbulb Created with Sketch. 674
    “Impressive” and “Outstanding” are not terms thrown around without due evidence.

    Congratulations to the brave patients who made this result possible - and thoughts to the families of those who were simply too far gone to benefit. Their sacrifice will save many lives in time.

    I know many of us are exhausted from years of dreadful, disconnected market conditions. I hope this release is a reminder of how rare and powerful - and safe - this molecule is.

    In time, bisantrene will return to the market and you can all say you were a small part of that.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.70
Change
0.090(5.59%)
Mkt cap ! $289.5M
Open High Low Value Volume
$1.60 $1.76 $1.59 $142.7K 84.97K

Buyers (Bids)

No. Vol. Price($)
2 17175 $1.70
 

Sellers (Offers)

Price($) Vol. No.
$1.77 6060 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.